Aristo Bio-Tech and Lifescience Temettü
Temettü kriter kontrolleri 3/6
Aristo Bio-Tech and Lifescience is a dividend paying company with a current yield of 0.28% that is well covered by earnings.
Anahtar bilgiler
0.3%
Temettü verimi
-13.3%
Geri Alım Getirisi
| Toplam Hissedar Getirisi | -13.1% |
| Gelecekteki Temettü Verimi | n/a |
| Temettü Büyümesi | n/a |
| Bir sonraki temettü ödeme tarihi | n/a |
| Eski temettü tarihi | n/a |
| Hisse başına temettü | ₹0.400 |
| Ödeme oranı | 7% |
Son temettü güncellemeleri
Recent updates
Aristo Bio-Tech and Lifescience Limited (NSE:ARISTO) Doing What It Can To Lift Shares
Oct 30
Is Aristo Bio-Tech and Lifescience (NSE:ARISTO) Using Too Much Debt?
Aug 22Potential Upside For Aristo Bio-Tech and Lifescience Limited (NSE:ARISTO) Not Without Risk
Jun 29If EPS Growth Is Important To You, Aristo Bio-Tech and Lifescience (NSE:ARISTO) Presents An Opportunity
Mar 22Ödemelerde İstikrar ve Büyüme
Temettü verilerini getirme
İstikrarlı Temettü: Too early to tell whether ARISTO's dividend payments have been stable as they only just started paying a dividend.
Büyüyen Temettü: Too early to tell if ARISTO's dividend payments are increasing as they only just started paying a dividend.
Piyasaya Karşı Temettü Getirisi
| Aristo Bio-Tech and Lifescience Piyasaya Karşı Temettü Getirisi |
|---|
| Segment | Temettü Verimi |
|---|---|
| Şirket (ARISTO) | 0.3% |
| Pazarın Alt %25'i (IN) | 0.2% |
| Pazarın En İyi %25'i (IN) | 1.1% |
| Sektör Ortalaması (Chemicals) | 0.7% |
| Analist tahmini (ARISTO) (3 yıla kadar) | n/a |
Önemli Temettü: ARISTO's dividend (0.28%) is higher than the bottom 25% of dividend payers in the Indian market (0.24%).
Yüksek Temettü: ARISTO's dividend (0.28%) is low compared to the top 25% of dividend payers in the Indian market (1.09%).
Hissedarlara Ödenen Kazanç
Kazanç Kapsamı: With its low payout ratio (7%), ARISTO's dividend payments are thoroughly covered by earnings.
Hissedarlara Nakit Ödeme
Nakit Akışı Kapsamı: With its reasonably low cash payout ratio (26%), ARISTO's dividend payments are well covered by cash flows.